Pharma — India Patent Cases
967 decisions indexed
Page 14 of 33 · 967 total
Glaxo Group Limited v.Dermazone Pharmaceuticals Private Limited
Glaxo Group Limited successfully secured an ad-interim injunction against Dermazone Pharmaceuticals in a trademark infringement suit. The Delhi High Court found that the Defendant's mark, 'BECLOVATE,' is phonetically and deceptively similar to the Plaintiff's registered mark, 'BETNOVATE.' Given the identical nature of the products (skin treatments) and strong market presence of Glaxo, the court granted immediate relief to prevent consumer confusion. The injunction restricts the manufacture and sale of the infringing product moving forward.
Bristol Myers Squibb Holdings Ireland Unlimited Company v.Triveni Interchem Private Limited
The dispute involved allegations of patent infringement concerning the drug 'Apixaban'. The parties reached separate settlement agreements with Defendants 1 & 2 and Defendant 3, mediated by the Delhi High Court. The court subsequently decreed the suit based on these terms.
Idorsia Pharmaceuticals Ltd v.The Assistant Controller Of Patents And Designs
Idorsia Pharmaceuticals Ltd appealed the Assistant Controller of Patents and Designs' order rejecting its patent application for 'N-substituted indole derivatives as PGE2 receptor modulators'. The appellant argued that it was not given a proper opportunity to justify the inclusion of the expression 'pharmaceutically acceptable salts' in its claims before the rejection. The High Court set aside the rejection order and remanded the matter.
Astrazeneca Ab v.USV Private Limited
AstraZeneca filed a suit for infringement against USV Private Limited regarding the pharmaceutical preparations covered by three patents, including those for 'TICAGRELOR'. The parties subsequently resolved their disputes amicably and filed an application under Order XXIII Rule 3 CPC to record the settlement.
Vifor International Ltd. v.Biological E Limited
Vifor International Ltd., the patentee, filed a suit against Biological E Limited regarding alleged infringement of its patent (IN 221536) covering water-soluble iron carbohydrate complexes. The dispute centers on the use and manufacture of FCM for intravenous iron deficiency therapy. Given the impending expiry of the patent tenure in October 2023, the court issued interim directions. These directions mandate that the defendants maintain detailed accounts of their manufacturing and sales of FCM until the patent expires, while simultaneously prohibiting them from using the specific process claimed by Vifor.
Vifor (International) Ltd. v.Eris Lifesciences Limited
This order addresses various applications seeking interim directions in suits related to the patent IN 221536. The court vacated previous status quo orders following a Coordinate Bench's dismissal of injunction applications, but imposed conditions that defendants must not follow the patented process and must maintain complete sales accounts.
Vifor (International) Ltd. v.Eris Lifesciences Limited
The plaintiffs sought interim directions based on a prior Division Bench order. The court noted that a Coordinate Bench had dismissed the plaintiffs' interim injunction applications concerning patent IN 221536. Consequently, the status quo orders previously passed were vacated, subject to conditions preventing defendants from following the patented process.
Vifor (International) Ltd. v.Eris Lifesciences Limited
The court addressed several interim applications filed by Vifor (International) Ltd. in various suits, primarily concerning the patent IN 221536 related to Water Soluble Iron Carbohydrate Complex. Following a prior judgment by a Coordinate Bench dismissing plaintiffs' interim injunction applications, the status quo orders were vacated, subject to conditions preventing defendants from following the patented process.
Vifor (International) Ltd. v.Eris Lifesciences Limited
This order addresses various applications seeking interim directions in multiple commercial suits related to Patent IN 221536. The court noted that a Coordinate Bench had dismissed the plaintiffs' interim injunction applications, leading to the vacation of previous status quo orders. The court declined to grant an immediate direction for deposit of entire sales amount but directed defendants to maintain and file complete accounts of sales.
Merck Sharp & Dohme Llc v.Sanjeev Gupta & Ors
The commercial suit for patent infringement (CS(COMM) 823/2018) between Merck Sharp & Dohme Llc and Sanjeev Gupta & Ors was settled. The parties agreed that the suit would be decreed in favor of the Plaintiffs, acknowledging the validity of Patent IN'816 and the Defendants' infringing activities.
Indoco Remedies Limited v.M/S.Micro Labs Ltd.
The Madras High Court disposed of a dispute between Indoco Remedies Limited and M/S.Micro Labs Ltd regarding the trade mark 'CITALIFT'. The parties reached an agreement, leading the court to mandate the cancellation of the disputed registration (No. 1005556). Micro Labs agreed to change its mark to 'MICROLIFT' while being granted a six-month grace period to liquidate existing inventory bearing the old mark.
Centaur Pharmaceuticals Pvt.Ltd v.La Renon Health Care Pvt.Ltd.
Centaur Pharmaceuticals Pvt.Ltd filed a suit against La Renon Health Care Pvt.Ltd. and Stanford Laboratories Pvt. Ltd. alleging infringement of their Patent No. 224100, seeking an injunction, accounts, seizure, and Rs. 1 crore in damages. However, the plaintiff subsequently withdrew the suit.
M/s. TIL Healthcare Private Limited v.The Registrar of Trade Marks
The Madras High Court allowed the appeal filed by TIL Healthcare Private Limited, setting aside the Trade Mark Office's refusal to register the mark 'URELOG'. The court found that despite objections based on similarity to existing marks, the appellant successfully demonstrated the distinctiveness of the word mark. By considering the specific derivation of the elements ('URE' from urea/urine and 'LOG' from ketoanalogue) and noting that the mark was not a self-evident fusion, the High Court directed the Registrar to accept the application for advertisement.
Jupiter Drugs Partnership Concern v.Mrs.M.Sarojini Proprietrix; The Deputy Registrar of Trademarks
Jupiter Drugs filed an Original Petition seeking to expunge or limit the registered trademark 'ZIPROVIT' (No. 1306475) held by Mrs. M. Sarojini Proprietrix, citing issues related to geographical scope and use. However, the Madras High Court dismissed the petition for non-prosecution because the petitioner could not be served notice due to an outdated address. This procedural dismissal effectively halted Jupiter Drugs' attempt to challenge the trademark registration.
Helsinn Healthcare Sa v.Zydus Healthcare Limited
The plaintiff alleged that the defendant was infringing Indian Patent No. 426553, which covers a combination therapy (Netupitant and Palonosetron) used as an antiemetic for CINV. The court registered the plaint as a suit and directed both parties to file their respective written statements and pleadings.
W R Grace And Co Conn v.The Controller Of Patents
W R Grace & Co Conn appealed the Patent Office's refusal of its patent application (201717030699), which related to a crystalline form of Nicotinamide Riboside. The refusal was based on lack of inventive step and failure to meet requirements under Sections 3(d) and 3(e). The Appellant subsequently filed amended claims restricting the scope to the method aspect, leading the Court to remand the matter for fresh examination by the Patent Office.
Dr. Reddys Laboratories Limited v.Fast Cure Pharma And Anr.
The Delhi High Court allowed a petition seeking the rectification of a trademark registration, declaring the mark 'RAZOFAST' illegal. The court found that 'RAZOFAST' was deceptively similar to the petitioner's prior registered mark 'RAZO', which is used for the pharmaceutical compound Rabeprazole. Consequently, the registration of 'RAZOFAST' was cancelled and removed from the register.
Dhanvantari Nano Ayushadi Private Limited v.The Registrar of Trade Marks
Dhanvantari Nano Ayushadi Private Limited filed a Civil Miscellaneous Appeal seeking to set aside an order passed by the Registrar of Trade Marks concerning the registration of the mark “NANO CUR”. The appeal was dismissed for non-prosecution because the appellant could not be served notice due to having vacated the specified office address.
Supernus Pharmaceuticals Inc v.The Assistant Controller of Patents and Designs, Government of India
Supernus Pharmaceuticals Inc filed a Transfer Civil Miscellaneous Appeal (Patents) challenging an earlier decision regarding its patent application. The appellant subsequently instructed their counsel to withdraw the appeal.
Mankind Pharma Limited v.4 Square Pharmaceuticals Of ... and The Registrar of Trade Marks
The Madras High Court dismissed a petition filed by Mankind Pharma Limited seeking the removal of Trademark No. 1803072 (XYDI). The court noted that the last registration for this trademark had expired on April 6, 2019. Since the underlying issue—the status of the mark's validity—had changed, the petition was deemed infructuous. Mankind Pharma was granted leave to re-apply should the trademark be restored.
Perennial Health Care India Private Limited v.Manju Bai & Ramesh Kumar M.Jain; The Registrar of Trademarks
The Madras High Court case involving Perennial Health Care India Private Limited and Manju Bai & Ramesh Kumar M.Jain was concluded when the petitioner chose to withdraw their original petitions. The petitions, which sought various remedies under the Trademarks Act, 1999, including removal of specific trademark entries in Class 5, were formally dismissed as withdrawn by the court on August 23, 2023.
Macleods Pharmaceuticals Limited v.Boehringer Ingelheim Pharma GmbH & Co. KG
Macleods Pharmaceuticals Limited filed an information alleging that Boehringer Ingelheim (OP-1 and OP-2) was abusing its patent rights, specifically using the Second Patent to prohibit competitors from using 'Linagliptin' after the First Patent expired. The Commission found no prima facie case warranting an investigation into the matter.
United Biotech Private Limited v.Sun Pharma Laboratories Limited
The Madras High Court allowed United Biotech Private Limited's petition seeking the removal of the trade mark 'ONCONASE' (No. 447044) registered in favour of Sun Pharma Laboratories Limited. The court found that the mark had not been used since its registration, thereby satisfying the grounds for cancellation under Section 47 of the Trade Marks Act, 1999. Consequently, the Registrar was directed to remove the entry from the Register within four weeks.
Pfizer Products Inc. v.R. Hanumantha Rao
Pfizer Products Inc. successfully petitioned the Madras High Court to expunge the registration of the trademark VECOREX (No. 980006) from the register. The court noted that the mark had not been renewed since December 29, 2020. Consequently, the court directed the Registrar of Trademarks to remove the entry within four weeks, effectively clearing the mark for potential use by the petitioner.
Mankind Pharma Limited v.Genova Biotechniques Pvt. Ltd.
Mankind Pharma Limited successfully petitioned the Madras High Court to remove a specific trademark, 'PSO KIND,' from the register. The court observed that while the mark was initially registered, its renewal had lapsed after November 8, 2020. Consequently, the time limit for both renewal and restoration had expired. The court directed the Registrar of Trademarks to cancel the registration certificate and remove the entry within four weeks.
Takeda Pharmaceutical Co. Ltd v.Controller Of Patents And Designs
Takeda Pharmaceutical Co. Ltd filed an appeal under Section 117A of the Patent Act, 1970, challenging the Deputy Controller of Patents & Designs' order dated April 12, 2023, which rejected its application for patent registration.
Dr. Reddys Laboratories Limited & Anr. v.The Controller Of Patents & Ors.
The petitioner sought a stay of proceedings in the patent revocation petition (CO (Comm. IPD-PAT) 3/2021) under Section 10 of the CPC, citing a previously instituted suit filed by Respondent 2 (Boehringer Ingelheim International GmbH) before the High Court of Himachal Pradesh. The court analyzed whether a revocation petition and an infringement suit have identical issues and causes of action.
Allegro Pharmaceuticals Llc v.The Controller of Patents and Designs
Allegro Pharmaceuticals LLC filed a Transfer Civil Miscellaneous Appeal (Patents) seeking to set aside an earlier order and amend its claims to secure a patent. However, the appellant subsequently instructed their counsel to withdraw the appeal.
Mankind Pharma Limited v.Neospark Drugs And Chemicals Private Limited; The Registrar of Trade Marks
The Madras High Court ruled in favor of Mankind Pharma Limited, directing the removal of the trademark MAXCAL GEL (No. 2102511) from the Trade Marks Register. The court found that the registration had lapsed and was not renewed within the statutory time limits. This decision underscores the strict adherence required to maintain trademark rights through timely renewal procedures.
Sun Pharma Laboratories Ltd v.B.B. Mohan Kumar Trading As East West Pharma & The Registrar of Trademarks
The Madras High Court dismissed the rectification petition filed by Sun Pharma Laboratories Ltd against Trademark No. 1764708. The court noted that the trademark in question had expired on December 17, 2018, and was not subsequently renewed. Consequently, the petitioner's request to remove the entry from the register became infructuous.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.